What action will the Commission take against pharmaceuticals companies that attempt to curtail parallel trading in the medicines sector?
Hvilke foranstaltninger vil Kommissionen træffe over for medicinalvirksomheder, der forsøger at begrænse parallelhandel i medicinalsektoren?